STOCK TITAN

SS Innovations reports dual-console beating-heart bypass

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

SS Innovations International, Inc. (SSII) announced the world’s first dual-console, beating-heart TECAB surgery using all five arms of its SSi Mantra system, performed by surgeons at Medanta - The Medicity Hospital in Gurugram, India. The Totally Endoscopic Coronary Artery Bypass was conducted while the heart continued beating, without opening the chest or using a heart-lung machine.

Medanta Chairman and Managing Director Dr. Naresh Trehan said the patient was doing extremely well. SSII says the SSi Mantra has been clinically validated in India in more than 190 different types of surgical procedures.

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Robotic arms used 5 arms Used in the dual-console, beating-heart TECAB surgery.
Control consoles used 2 consoles Dual-console control was used for the TECAB surgery.
Surgical procedure types clinically validated More than 190 different types SSi Mantra clinical validation in India.
Totally Endoscopic Coronary Artery Bypass (TECAB) medical
"Totally Endoscopic Coronary Artery Bypass (“TECAB”) surgery"
beating-heart approach medical
"The beating-heart approach allows surgeons to perform the bypass"
sternotomy medical
"unlike a conventional sternotomy"
A sternotomy is a surgical cut through the breastbone to open the chest so surgeons can reach the heart and nearby organs; think of it like opening a book to access the pages inside. It matters to investors because the approach influences procedure risk, recovery time, hospital length of stay, device design and adoption, and ultimately costs and reimbursement—factors that affect revenue and liability for hospitals, device makers and insurers.
dual-console control technical
"under dual-console control"
minimally invasive cardiac surgery medical
"application of robotics to minimally invasive cardiac surgery"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What was SSII’s first dual-console TECAB procedure?

SSII announced that surgeons performed the world’s first dual-console, beating-heart TECAB surgery using all five SSi Mantra arms at Medanta Hospital in Gurugram, India.

How was the beating-heart TECAB procedure performed?

The procedure used small incisions without opening the chest; the bypass was performed while the heart continued beating and without a heart-lung machine, unlike a conventional sternotomy.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001676163 FL IN 0001676163 2026-11-19 2026-11-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): November 19, 2026

 

SS INNOVATIONS INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

 

Florida   001-42615   47-3478854

(State or Other Jurisdiction

of Incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

405, 3rd Floor, iLabs Info Technology Centre

Udyog Vihar, Phase III

Gurugram, Haryana India

  122016
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: +91 73375 53469

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class   Trading Symbol   Name of each exchange on which registered
Common Stock   SSII   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

As used in this Current Report on Form 8-K (this “Current Report”), the terms “SSi,” “the Company,” “we,” “us” and “our” refer to SS Innovations International, Inc. and its subsidiaries.

 

Item 8.01 Other Events.

 

On November 19, 2026, SSi issued a press release announcing that a team of surgeons successfully completed the world’s first dual-console, beating-heart Totally Endoscopic Coronary Artery Bypass (“TECAB”) surgery utilizing all five arms of the Company’s SSi Mantra surgical robotic system at Medanta - The Medicity Hospital in Gurugram, India.

 

A copy of the press release is included as Exhibit 99.1 to this Current Report.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
99.1   Press Release, dated November 19, 2026
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: November 19, 2026 SS INNOVATIONS INTERNATIONAL, INC.
     
  By: /s/ Sudhir Srivastava
    Sudhir Srivastava, M.D.
    Chairman and Chief Executive Officer

 

2

 

Exhibit 99.1

 

 

SS Innovations Announces World’s First Dual-Console, Beating-Heart TECAB Surgery Utilizing

All Five Arms of the SSi Mantra Surgical Robotic System

 

Landmark procedure successfully performed at Medanta Hospital in Gurugram, India, demonstrating the power of dual-console technology in complex robotic cardiac surgeries

 

FORT LAUDERDALE, Fla. – November 19, 2026 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that a team of surgeons successfully completed the world’s first dual-console, beating-heart Totally Endoscopic Coronary Artery Bypass (“TECAB”) surgery utilizing all five arms of the Company’s SSi Mantra surgical robotic system (the “SSi Mantra”) at Medanta - The Medicity Hospital (“Medanta Hospital”) in Gurugram, India.

 

Dr. Nitin Kumar Rajput of Medanta Hospital and Dr. Lalit Malik of Manipal Hospital, Jaipur, successfully performed the beating-heart TECAB procedure using two separate consoles and the SSi Mantra, under the guidance of Dr. Sudhir Srivastava, the Company’s Chairman of the Board and Chief Executive Officer. The two surgeons completed the complex cardiac procedure using all five of the SSi Mantra’s arms simultaneously, in complete synchronization, under a dual-console configuration. A heart stabilization system steadied the target area while the patient’s heart continued to beat.  

(Dr. Rajput and Dr. Malik performing the world's first dual-console, beating-heart TECAB surgery utilizing all five arms of the SSi Mantra at Medanta Hospital in Gurugrum, India)

 

TECAB surgery is a highly complex form of a coronary artery bypass procedure performed through small incisions, without opening the chest, unlike a conventional sternotomy. The beating-heart approach allows surgeons to perform the bypass while the heart continues to beat, without using a heart-lung machine. Combining this technique with a five-arm robotic configuration under dual-console control marks a significant advancement in the application of robotics to minimally invasive cardiac surgery.

 

For video highlights of the dual-console, beating-heart TECAB surgery, please visit: link.

 

 
 

 

Dr. Srivastava commented, “The successful use of dual-console control and five robotic arms in a beating-heart TECAB procedure demonstrates the advanced capabilities of the SSi Mantra in enabling complex minimally invasive cardiac surgeries. Our mission at SS Innovations is to democratize access to world-class robotic surgery, including the most intricate cardiac procedures, and this achievement brings us a step closer to that goal.”

 

Dr. Naresh Trehan, Chairman and Managing Director of Medanta Hospital, said, “I am delighted to share with you that we have performed the first coronary bypass surgery using the SSi Mantra robot where we have used five arms and a dual console. This is the first time that this has been done in the world, and the patient is doing extremely well. The robot, and the whole procedure went marvelously, and everything went according to schedule. I believe that this innovation by Dr. Sudhir Srivastava and his team at SS Innovations has really transformed the way we will do robotic surgery in the future. Today is a landmark day from our point of view.”

 

Dr. Rajput said, “Performing a complex beating-heart bypass procedure using five robotic arms and two control consoles requires precision, coordination and close collaboration between the surgeons. This approach allowed us to work in synchronization throughout the procedure. The patient’s recovery following surgery was encouraging and reinforces the potential of minimally invasive robotic techniques in advancing cardiac care.”

 

Dr. Malik added, “This procedure marks an important step in the evolution of robotic cardiac surgery. The dual-console setup enabled coordinated control between the two surgeons, while the five-arm configuration supported the technical demands of the operation. Such advancements can help expand the possibilities of minimally invasive cardiac procedures and improve the overall surgical experience for patients.”

 

For a video message from Dr. Srivastava, please visit: link.

 

For a video message from Dr. Trehan, please visit: link.

 

About SS Innovations

 

SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures, including cardiac surgery. Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company’s website at ssinnovations.com or LinkedIn for more information and updates.

 

2
 

 

About the SSi Mantra

 

The SSi Mantra surgical robotic system is a modular, multi-arm system with advanced technology features, including 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, a touch-panel monitor for displaying all patient-related information, a virtual real-time image of the robotic patient-side arm carts, and the ability to superimpose 3D models of diagnostic imaging. The optional SSi MantrAsana tele-surgeon console is a portable, compact alternative to the SSi Mantra’s standard surgeon command center that is intended to provide equivalent control functionality while enabling enhanced portability, ergonomic flexibility, and telesurgery capability. The SSi Mantra utilizes over 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery, and 5 mm instruments for the pediatric population and ENT surgeries. A vision cart is designed to provide the table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra has been clinically validated in India in more than 190 different types of surgical procedures.

 

Forward-Looking Statements

 

This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions identify such forward-looking statements. These statements relate to future events or SS Innovations’ future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

 

Investor Contact:

 

The Equity Group

Kalle Ahl, CFA

T: (303) 953-9878

kalle.ahl@theequitygroup.com

 

Devin Sullivan, Managing Director

T: (212) 836-9608

devin.sullivan@theequitygroup.com

 

Media Contact:

 

RooneyPartners LLC

Kate Barrette

T: (212) 223-0561

kbarrette@rooneypartners.com

 

3

 

Filing Exhibits & Attachments

4 documents

Keep reading